A 12-month randomized controlled study of the aldose reductase inhibitor ponalrestat in patients with chronic symptomatic diabetic neuropathy.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FC151ADB.svg?ark=w1%2F20260515%2FFC151ADB)](https://nobleid.org/work/w1/20260515/FC151ADB)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors